Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Total Non-Current Liabilities (2016 - 2025)

Fortress Biotech has reported Total Non-Current Liabilities over the past 13 years, most recently at $121.9 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $121.9 million for Q4 2025, down 15.4% from a year ago — trailing twelve months through Dec 2025 was $121.9 million (down 15.4% YoY), and the annual figure for FY2025 was $121.9 million, down 15.4%.
  • Total Non-Current Liabilities for Q4 2025 was $121.9 million at Fortress Biotech, up from $114.6 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for FBIO hit a ceiling of $242.4 million in Q4 2022 and a floor of $114.6 million in Q3 2025.
  • Median Total Non-Current Liabilities over the past 5 years was $165.4 million (2023), compared with a mean of $171.8 million.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 71.26% in 2021 and later tumbled 32.33% in 2023.
  • Fortress Biotech's Total Non-Current Liabilities stood at $168.6 million in 2021, then soared by 43.8% to $242.4 million in 2022, then tumbled by 32.33% to $164.0 million in 2023, then fell by 12.15% to $144.1 million in 2024, then dropped by 15.4% to $121.9 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $121.9 million (Q4 2025), $114.6 million (Q3 2025), and $120.8 million (Q2 2025) per Business Quant data.